Related Experiment Video
Updated: May 25, 2026

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology
Published on: August 18, 2014
[Botulinum toxin for neurogenic bladder dysfunction]
1Abteilung für Urologie, St. Hedwig Kliniken, Große Hamburger Straße 5-11, 10115 Berlin, Deutschland. H.Schulte-Baukloh@alexius.de
Botulinum neurotoxin A (BoNT/A) injections effectively treat neurogenic bladder disorders by improving symptoms and bladder function. Repeated treatments are safe and necessary as effectiveness diminishes after approximately nine months.
Area of Science:
- Urology
- Neurology
Context:
- Botulinum neurotoxin (BoNT) has gained prominence in treating neurogenic bladder dysfunction over the past 12 years.
- It offers an alternative to conservative therapies and reduces the need for surgical interventions.
- Botulinum neurotoxin A (BoNT/A) has been approved for neurogenic bladder disorders since September 2011.
Purpose:
- To summarize key findings on the practical application of BoNT/A for neurogenic bladder disorders.
- To review the efficacy and safety of BoNT/A in urological practice.
Summary:
- Botulinum neurotoxin A (BoNT/A) is the most utilized subtype, demonstrating significant efficacy via detrusor injections.
- Full therapeutic effects manifest within approximately seven days.
- Improvements include enhanced bladder capacity, reduced maximum detrusor pressure, and better subjective parameters like reduced urination frequency, incontinence, and improved quality of life.
- Effectiveness wanes after about nine months, necessitating repeated injections, which have proven effective.
- Systemic side effects are rare; however, increased residual urine leading to urinary retention is a notable urologic side effect.
Impact:
- BoNT/A injections offer a minimally invasive treatment option for neurogenic bladder dysfunction.
- The treatment improves patient quality of life and reduces reliance on more invasive procedures.
- Understanding the duration of effect and potential side effects is crucial for patient management and optimizing treatment outcomes.
Related Concept Videos
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Skeletal Muscle Relaxants: Therapeutic Uses
Urinary Bladder
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
The Micturition Reflex
The process begins with bladder filling, where the bladder wall stretches as urine accumulates. This stretching activates the urine storage reflex, mediated by the sacral spinal segments and the pontine storage center. Efferent sympathetic impulses stimulate the detrusor muscle to relax and the internal urethral sphincter to contract, facilitating urine...
